Broader screening helps reduce C. difficile infection
The rate of C. difficile infection among hospitalized patients drops dramatically when all patients are tested for the bacteria before being admitted to hospital, says a clinical study headed by a JGH physician and researcher.
Key mechanism identified in deadly brain tumours
A key to understanding the formation of the most aggressive type of brain tumour in adults has been revealed at the JGH.
Focus on youth at 11th annual Psychiatry Research Day
Youths at risk were the focus of discussions among healthcare professionals in the mental health field at the JGH Department of Psychiatry’s 11th annual Research Day in April.
Drug shows promise for those trying to quit smoking after a heart attack
Nearly half of the heavy smokers who were admitted to hospital after a heart attack had successfully quit smoking six months after being given the drug varenicline.
Congratulations
Dr. Mark Wainberg, Director of the HIV/AIDS research section in the Lady Davis Institute at the JGH, has been inducted into the Canadian Medical Hall of Fame in recognition for his pioneering work and social activism.
New hope for dry eye sufferers
People who suffer from chronic dry eye disease have new hope for relief, with the development of a promising treatment.
Warning against “genetic over-diagnosis” in breast cancer screening
It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.
Pioneering effort to apply novel biotechnology to cancer research
The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.
Research roundup
Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, has received the 2015 Award for Excellence in Human Genetics Education from the American Society of Human Genetics.
New revelations about a possible pathway to Alzheimer’s disease
Elevated levels of a particular protein, known as Capase-6, in a specific area of the brain can serve as an early indicator for the onset of the type of cognitive impairment that is characteristic of Alzheimer’s disease.